New theories for older problems

Sleep Medicine Reviews

Volumn 10, Issue 4, 2006, Pages 211-213

  Morgan, Kevin ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; HYPNOTIC AGENT; MELATONIN;

AGING; AROUSAL; BEHAVIOR THERAPY; BRAIN DYSFUNCTION; COGNITION; COGNITIVE THERAPY; COMORBIDITY; EDITORIAL; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HOMEOSTASIS; HUMAN; INSOMNIA; MANAGEMENT; NEUROPHYSIOLOGY; NIGHT SLEEP; NONREM SLEEP; PARIETAL LOBE; PREFRONTAL CORTEX; SELECTIVE ATTENTION; SELF MEDICATION; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDER; TASK PERFORMANCE; THEORY; WORKING MEMORY;

AGED; COGNITIVE THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPNOTICS AND SEDATIVES; RESEARCH; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 33746295403     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2006.03.007     Document Type: Editorial

References (17)

1. Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Klassen TP, et al. Manifestations and management of chronic insomnia in adults. Evidence Report/Technology Assessment No. 125. (Prepared by the University of Alberta Evidence-based Practice Center, under Contract No. C400000021.) AHRQ Publication No. 05-E021-2. Rockville, MD: Agency for Healthcare Research and Quality, June 2005.
2. Glass J., Lanctôt K.L., Herrmann N., Sproule B.A., and Busto U.E. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331 (2005) 1169-1175
3. Buscemi N., Vandermeer B., Hooton N., Pandya R., Tjosvold L., Hartling L., et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 332 (2006) 385-393
4. Stepanski E.J., and Rybarczyk B. Emerging research on the treatment and etiology of secondary or comorbid insomnia. Sleep Med Rev 10 (2006) 7-18
5. Lichstein K.L. Secondary insomnia: a myth dismissed. Sleep Med Rev 10 (2006) 3-5
6. Espie C.A., Broomfield N.M., MacMahon K.M.A., Macphee L.M., and Taylor L.M. The attention-intention-effort pathway in the development of Psychophysiologic Insomnia: theoretical review. Sleep Med Rev 10 (2006) 215-245
7. Pigeon W.R., and Perlis M.L. Sleep homeostasis in primary insomnia. Sleep Med Rev 10 (2006) 247-254
8. Cortoos A., Verstraeten E., and Cluydts R. Neurophysiological aspects of primary insomnia: implications for its treatment. Sleep Med Rev 10 (2006) 255-266
9. Harvey A.G. A cognitive model of insomnia. Behav Res Therapy 40 (2002) 869-893
10. Borkovec T.D. Insomnia. J Consult Clin Psychol 50 (1982) 880-895
11. Ascher L.M., and Turner R.M. Paradoxical intention and insomnia-an experimental investigation. Behav Res Therapy 17 (1979) 408-411
12. Gaillard J.M. Is insomnia a disease of slow-wave sleep?. Eur Neurol 14 (1976) 473-484
13. Hauri P. Treating psychophysiologic insomnia with biofeedback. Arch Gen Psychiatry 38 (1981) 752-758
14. Johnson L.C., and Chernik D.A. Sedative-hypnotics and human performance. Psychopharmacology 76 (1982) 101-113
15. State-of-the-Science Panel. National Institutes of Health State of the Science Conference Statement: manifestations and management of chronic insomnia in adults, June 13-15, 2005. Sleep 28 (2005) 1049-1057
16. Milham M.P., Erickson K.I., Banich M.T., Kramer A.F., Webb A., Wszalek T., et al. Attentional control in the aging brain: insights from an fMRI study of the Stroop task. Brain Cognition 49 3 (2002) 277-296
17. Fichten C.S., Libman E., Bailes S., and Alapin I. Characteristics of older adults with insomnia. In: Lichstein K.L., and Morin C.M. (Eds). Treatment of late life insomnia (2000), Sage Publications Inc, Thousand Oaks 37-79